You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

List of Excipients in Branded Drug KLOR CON M


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for KLOR CON M

Last updated: February 26, 2026

What Is KLOR CON M?

KLOR CON M is a pharmaceutical product containing a combination of potassium chloride (KCl) with magnesium chloride (MgCl). Used primarily as a supplement to treat or prevent low potassium and magnesium levels in patients with electrolyte imbalances, particularly in cases of hypokalemia and hypomagnesemia. The formulation aims to combine both minerals in a single oral dosage form to improve compliance and therapeutic efficacy.

What Are the Key Excipient Components in KLOR CON M?

The excipient strategy for KLOR CON M involves selecting agents that ensure stability, palatability, and bioavailability while complying with regulatory standards. Its formulation generally includes:

  • Binders and fillers: Microcrystalline cellulose, for tablet compression.
  • Disintegrants: Croscarmellose sodium to facilitate breakup.
  • Lubricants: Magnesium stearate for tablet manufacturing.
  • Taste-masking agents: Artificial sweeteners (e.g., aspartame or sucralose) and flavoring agents.
  • Protective agents: Buffering agents to maintain pH stability.

The specific excipient composition varies among manufacturers but aims to optimize dissolution, minimize gastrointestinal irritation, and improve patient acceptability.

What Are the Critical Factors in Excipient Selection for KLOR CON M?

Stability

Excipients must maintain the chemical stability of potassium and magnesium salts. Some salts are hygroscopic, requiring desiccants or moisture barriers to prevent degradation.

Bioavailability

Excipients influence dissolution properties; disintegrants and solubilizers (e.g., mannitol) are crucial to ensure rapid release and absorption of minerals.

Palatability

Taste-masking agents are essential since potassium salts often have a bitter taste. Sweeteners and flavor enhancers improve patient adherence.

Compatibility

Selected excipients should not react with active ingredients. For example, acids or bases that alter pH could compromise salt stability or increase tablet friability.

Manufacturing Considerations

Excipients should enable scalable, cost-effective production. Compatibilities with high-speed machinery and stability during storage are critical factors.

What Commercial Opportunities Exist for Excipient Optimization?

Formulation Innovation

Developing controlled-release formulations can allow for steady electrolyte levels, reducing adverse events and improving compliance.

Novel Taste-Masking Technologies

Enhanced taste-masking systems, such as microencapsulation, can distinguish KLOR CON M in over-the-counter (OTC) markets or in pediatric formulations.

Alternative Delivery Systems

Liquid formulations, patches, or dispersible tablets could expand market reach, especially for pediatric or elderly populations.

Biosimilar and Generic Development

Partnerships with excipient suppliers to supply high-quality, cost-efficient excipients can lower manufacturing costs and facilitate market entry for generics.

Regulatory Trends

Stringent regulators emphasize safety and excipient transparency. Firms that identify excipients with favorable safety profiles and clear documentation can gain advantage in approval processes.

What Are the Challenges in Excipient Strategy for KLOR CON M?

  • Moisture sensitivity: Mineral salts risk hygroscopic degradation which necessitates moisture-resistant packaging.
  • Taste masking: Achieving effective taste suppression remains complex due to mineral salts' inherent bitterness.
  • Interaction risks: Compatibility issues with excipients that alter pH or cause chemical reactions.
  • Regulatory compliance: Variability in excipient approval status across markets complicates global positioning.

How Does the Market Landscape Impact Excipient Strategy?

The global electrolyte supplement market is projected to reach USD 4.2 billion by 2027 (CAGR of 7.2%) [1]. Increasing prevalence of chronic diseases, renal disorders, and electrolyte imbalances drive demand. This creates opportunities for optimizing excipient choices to produce cost-effective, patient-friendly formulations that meet regulatory standards.

The rise in OTC electrolyte products emphasizes the need for palatable, safe excipients. Personalized medicine trends also portend tailored excipient strategies to cater to specific demographic needs.

Summary of the Commercial Strategy

  • Focused on developing formulations that enhance stability, efficacy, and patient adherence.
  • Emphasize innovative taste-masking to capture pediatric and OTC markets.
  • Leverage advanced manufacturing techniques for cost reduction.
  • Ensure regulatory compliance and transparency in excipient usage.
  • Expand into alternative delivery systems to broaden access.

Key Takeaways

  • Excipient selection for KLOR CON M focuses on stability, bioavailability, palatability, and manufacturability.
  • Strategies include controlled-release designs, taste-masking, and novel delivery formats.
  • Commercial opportunities involve formulation innovation, excipient cost optimization, and market expansion through new delivery systems.
  • Challenges include hygroscopic salts, taste issues, and regulatory compliance.
  • Growth in electrolyte supplement markets underscores reliance on optimized excipient strategies to sustain competitive advantage.

FAQs

1. What are the primary criteria for excipient selection in electrolyte supplements?

Excipients must ensure chemical stability, facilitate rapid dissolution, mask unpleasant tastes, be compatible with active ingredients, and support scalable manufacturing.

2. How can taste masking be improved in KLOR CON M formulations?

Using high-efficiency sweeteners like sucralose combined with microencapsulation techniques can effectively suppress bitterness while maintaining formulation integrity.

3. Are there regulatory restrictions on excipients used in electrolyte supplements?

Yes. Certain excipients require approval by authorities such as the FDA or EMA. Manufacturers must provide detailed safety and stability data for excipients used in specific markets.

4. What innovations are shaping the future of electrolyte supplement formulations?

Controlled-release technologies, alternative delivery formats (liquids, dispersible tablets), and taste-masking advancements create opportunities to broaden patient adherence.

5. How does excipient choice influence the cost structure?

Utilizing cost-effective excipients without compromising quality can reduce manufacturing expenses, allowing competitive pricing and higher profit margins.


References

[1] MarketsandMarkets. (2022). Global electrolyte supplements market size, trends, and forecasts.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.